Skip to content

Press Release · Press Releases · United States

Alpheus Presents Data on Serial LDH Kinetics as a Potential Blood-Based Biomarker in Glioblastoma

Issued by PR Newswire

Image: PR Newswire

Exploratory analysis presented at the ESMO Congress suggests changes in lactate dehydrogenase (LDH) measurements over time may complement imaging in assessing disease activity in glioblastoma CHANHASSEN, Minn., Oct. 27, 2026 /PRNewswire/ -- Alpheus Medical, Inc., a clinical-stage oncology...

This press release summary is reproduced from the issuer's public feed.

Read the full release at PR Newswire

Original publisher: PR Newswire

Spotted an error? Request a correction · Corrections Policy

Related stories